Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Warm Autoimmune Hemolytic Anemia
Related studies linked through entity extraction aliases.
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
- Status
- RECRUITING
- Phase
- PHASE2
Sirolimus in the Treatment of Refractory/Relapsed wAIHA
- Status
- RECRUITING
- Phase
- NA
Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia
- Status
- WITHDRAWN
- Phase
- PHASE2
ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia
- Status
- WITHDRAWN
- Phase
- PHASE2
To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)
- Status
- COMPLETED
- Phase
- PHASE2
A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Rituximab in Auto-Immune Hemolytic Anemia
- Status
- COMPLETED
- Phase
- PHASE3